Lipella pharmaceuticals completes enrollment in phase 2a trial of lp-310 for oral lichen planus

Topline results expected q2 2025 listen: pittsburgh, april 08, 2025 – prism mediawire – lipella pharmaceuticals inc.

LIPO Ratings Summary

LIPO Quant Ranking